Unique role for the T cell receptor in retrovirus binding by the C6VL thymoma

Research output: Contribution to journalArticleResearchpeer-review

5 Citations (Scopus)

Abstract

Binding of cognate Radiation leukemia virus (RadLV) by the C6VL/1 thymoma involves a subset of TCR molecules in association with CD4 molecules expressed by that cell line. A CD4- variant of C6VL/1 has now been isolated which also has RadLV binding capacity. Stable expression of the TCR, class I, and CD5 molecules but not Thy1.2 and CD4 molecules has been demonstrated, and the C6VL/1 origin of this cell has been confirmed by Southern blot analysis using probes specific for the TCR beta chain gene. This cell line has maintained binding capacity for RadLV/C6VL prepared as an immunoabsorbent matrix, but unlike the parent C6VL/1 cell line, binds significantly less well to the related RadLV/VL3 isolate. Binding of the variant cell line to RadLV/C6VL can be completely inhibited by anti-clonotypic antibody to the TCR but only weakly by anti-H-2Kb antibody used at the same concentration. These data suggest that the TCR on C6VL/1 can interact with RadLV in the absence of any co-receptor function of CD4 and implicates the TCR as a sufficient receptor for retrovirus.

Original languageEnglish
Pages (from-to)377-380
Number of pages4
JournalInternational Immunology
Volume2
Issue number4
DOIs
Publication statusPublished - 1990
Externally publishedYes

Fingerprint

Radiation Leukemia Virus
Thymoma
Retroviridae
T-Cell Antigen Receptor
CD4 Antigens
Cell Line
Virus Attachment
Southern Blotting
Anti-Idiotypic Antibodies
Antibodies

Cite this

@article{771982bfd0b04f06a90e19fa30e3abd3,
title = "Unique role for the T cell receptor in retrovirus binding by the C6VL thymoma",
abstract = "Binding of cognate Radiation leukemia virus (RadLV) by the C6VL/1 thymoma involves a subset of TCR molecules in association with CD4 molecules expressed by that cell line. A CD4- variant of C6VL/1 has now been isolated which also has RadLV binding capacity. Stable expression of the TCR, class I, and CD5 molecules but not Thy1.2 and CD4 molecules has been demonstrated, and the C6VL/1 origin of this cell has been confirmed by Southern blot analysis using probes specific for the TCR beta chain gene. This cell line has maintained binding capacity for RadLV/C6VL prepared as an immunoabsorbent matrix, but unlike the parent C6VL/1 cell line, binds significantly less well to the related RadLV/VL3 isolate. Binding of the variant cell line to RadLV/C6VL can be completely inhibited by anti-clonotypic antibody to the TCR but only weakly by anti-H-2Kb antibody used at the same concentration. These data suggest that the TCR on C6VL/1 can interact with RadLV in the absence of any co-receptor function of CD4 and implicates the TCR as a sufficient receptor for retrovirus.",
author = "O'Neill, {H C}",
year = "1990",
doi = "10.1093/intimm/2.4.377",
language = "English",
volume = "2",
pages = "377--380",
journal = "International Immunology",
issn = "0953-8178",
publisher = "OXFORD UNIV PRESS",
number = "4",

}

Unique role for the T cell receptor in retrovirus binding by the C6VL thymoma. / O'Neill, H C.

In: International Immunology, Vol. 2, No. 4, 1990, p. 377-380.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - Unique role for the T cell receptor in retrovirus binding by the C6VL thymoma

AU - O'Neill, H C

PY - 1990

Y1 - 1990

N2 - Binding of cognate Radiation leukemia virus (RadLV) by the C6VL/1 thymoma involves a subset of TCR molecules in association with CD4 molecules expressed by that cell line. A CD4- variant of C6VL/1 has now been isolated which also has RadLV binding capacity. Stable expression of the TCR, class I, and CD5 molecules but not Thy1.2 and CD4 molecules has been demonstrated, and the C6VL/1 origin of this cell has been confirmed by Southern blot analysis using probes specific for the TCR beta chain gene. This cell line has maintained binding capacity for RadLV/C6VL prepared as an immunoabsorbent matrix, but unlike the parent C6VL/1 cell line, binds significantly less well to the related RadLV/VL3 isolate. Binding of the variant cell line to RadLV/C6VL can be completely inhibited by anti-clonotypic antibody to the TCR but only weakly by anti-H-2Kb antibody used at the same concentration. These data suggest that the TCR on C6VL/1 can interact with RadLV in the absence of any co-receptor function of CD4 and implicates the TCR as a sufficient receptor for retrovirus.

AB - Binding of cognate Radiation leukemia virus (RadLV) by the C6VL/1 thymoma involves a subset of TCR molecules in association with CD4 molecules expressed by that cell line. A CD4- variant of C6VL/1 has now been isolated which also has RadLV binding capacity. Stable expression of the TCR, class I, and CD5 molecules but not Thy1.2 and CD4 molecules has been demonstrated, and the C6VL/1 origin of this cell has been confirmed by Southern blot analysis using probes specific for the TCR beta chain gene. This cell line has maintained binding capacity for RadLV/C6VL prepared as an immunoabsorbent matrix, but unlike the parent C6VL/1 cell line, binds significantly less well to the related RadLV/VL3 isolate. Binding of the variant cell line to RadLV/C6VL can be completely inhibited by anti-clonotypic antibody to the TCR but only weakly by anti-H-2Kb antibody used at the same concentration. These data suggest that the TCR on C6VL/1 can interact with RadLV in the absence of any co-receptor function of CD4 and implicates the TCR as a sufficient receptor for retrovirus.

U2 - 10.1093/intimm/2.4.377

DO - 10.1093/intimm/2.4.377

M3 - Article

VL - 2

SP - 377

EP - 380

JO - International Immunology

JF - International Immunology

SN - 0953-8178

IS - 4

ER -